GenHealth.ai
Markets
Use Cases
Products
Company
Docs
Get a Demo
Automated Prior Authorization
with Generative AI. See how we support health plans and providers with prior auth.
Generative AI Healthcare Analytics
Use natural language to ask any question of your data: past, present, and future.
Search all medical codes
J0180
Injection, agalsidase beta, 1 mg
HCPCS code
Medical Policies and Guidelines for Injection, agalsidase beta, 1 mg
Related policies from health plans
ANTHEM-BLUECROSS-CA
Fabrazyme (agalsidase beta)
CIGNA
Diagnostic Nasal/Sinus Endoscopy, Functional Endoscopic Sinus Surgery (FESS) and Turbinectomy - (0554)
CIGNA
Diagnostic Nasal/Sinus Endoscopy, Functional Endoscopic Sinus Surgery (FESS) and Turbinectomy - (0554)
CIGNA
Diagnostic Nasal/Sinus Endoscopy, Functional Endoscopic Sinus Surgery (FESS) and Turbinectomy - (0554)
CIGNA
Diagnostic Nasal/Sinus Endoscopy, Functional Endoscopic Sinus Surgery (FESS) and Turbinectomy - (0554)
CIGNA
Diagnostic Nasal/Sinus Endoscopy, Functional Endoscopic Sinus Surgery (FESS) and Turbinectomy - (0554)
CIGNA
Diagnostic Nasal/Sinus Endoscopy, Functional Endoscopic Sinus Surgery (FESS) and Turbinectomy - (0554)
CIGNA
Diagnostic Nasal/Sinus Endoscopy, Functional Endoscopic Sinus Surgery (FESS) and Turbinectomy - (0554)
CIGNA
Diagnostic Nasal/Sinus Endoscopy, Functional Endoscopic Sinus Surgery (FESS) and Turbinectomy - (0554)
CIGNA
Drug-Eluting Devices for Use Following Endoscopic Sinus Surgery - (0481)
Similar Codes
ICD10CM codes
Z29.13
- Encounter for prophylactic Rho(D) immune globulin
Z30.013
- Encounter for initial prescription of injectable contraceptive
T80.90XA
- Unspecified complication following infusion and therapeutic injection, initial encounter
Z30.42
- Encounter for surveillance of injectable contraceptive
T80.90
- Unspecified complication following infusion and therapeutic injection
Z29.1
- Encounter for prophylactic immunotherapy
Z29.14
- Encounter for prophylactic rabies immune globin
T80.90XD
- Unspecified complication following infusion and therapeutic injection, subsequent encounter
T80.90XS
- Unspecified complication following infusion and therapeutic injection, sequela
T80.9XXA
- Unspecified complication following infusion, transfusion and therapeutic injection, initial encounte
HCPCS codes
J0180
- Injection, agalsidase beta, 1 mg
J0178
- Injection, aflibercept, 1 mg
J2840
- Injection, sebelipase alfa, 1 mg
J1322
- Injection, elosulfase alfa, 1 mg
J0202
- Injection, alemtuzumab, 1 mg
J0485
- Injection, belatacept, 1 mg
J1826
- Injection, interferon beta-1a, 30 mcg
J0221
- Injection, alglucosidase alfa, (lumizyme), 10 mg
J9171
- Injection, docetaxel, 1 mg
J0878
- Injection, daptomycin, 1 mg
CPT4 codes
82963
- Glucosidase, beta
90284
- Immune globulin (SCIg), human, for use in subcutaneous infusions, 100 mg, each
0031A
- Janssen Covid-19 Vaccine Administration
86146
- Beta 2 Glycoprotein I antibody, each
90371
- Hepatitis B immune globulin (HBIg), human, for intramuscular use
90281
- Immune globulin (Ig), human, for intramuscular use
90385
- Rho(D) immune globulin (RhIg), human, mini-dose, for intramuscular use
82785
- Gammaglobulin (immunoglobulin); IgE
85240
- Clotting; factor VIII (AHG), 1-stage
38790
- Injection procedure; lymphangiography